Neurelis' Series B - II Round

Neurelis raised a round of funding on December 07, 2017.

Neurelis is a privately-held San Diego-based specialty pharmaceutical company organized to license, develop, and commercialize product candidates for epilepsy and the broader central nervous system (C…

Articles about Neurelis' Series B - II Round: